This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Republican lawmakers in the House have introduced a bill Tuesday that tightens eligibility and public reporting requirements within the 340B Drug Discount Program, earning the applause of industry | Critics of the increasingly scrutinized 340B program applauded a new bill that tightens eligibility and public reporting requirements.
to 15% less pharmaceutical innovation. However, we argue that a typical long-run elasticity associated with U.S. revenues lies within the range of 0.25 implying that for every 10% reduction in expected revenues, we can expect 2.5% What is driving the variability in these estimates? Certainly different study designs matter (see below).
There's no shortage of attention on rising pharmaceutical costs, but policymakers need to have the full picture of trends in this space to work off of, according to a new study.
In a time when healthcare is always changing, the pharmaceutical sector is under more pressure to ensure patient safety while maintaining compliance with stringent regulatory standards. As the complexity of pharmaceutical delivery rises, technology has become ever more crucial in tracking and safeguarding pharmacological products.
But with all the regulations, can pharmaceutical marketers really utilize influencers to reach consumers and HCPs? This episode is essential listening for pharmaceutical and other healthcare leaders looking for modern ways to engage their audience, increase brand awareness, and boost sales. I'm a pharmaceutical physician.
The complaint alleges nearly two dozen pharmaceutical companies colluded to limit competition, causing costs for certain generic medications to skyrocket.
Providers are expected to seek rate increases from payers as they struggle with labor costs, while health plans will face pressure from increased pharmaceutical expenses.
The growing burden of pharmaceuticals is expected to be the primary driver of higher healthcare spending in 2025, mostly due to expensive GLP-1 drugs in demand for weight loss, according to the Business Group on Health.
A lot of people when they look at pharmaceutical prices think they are ‘too high’ or ‘too low’ But the question is, too high or too low relative to what? What are our goals in pharmaceutical pricing. That is the title of a fantastic editorial from Olivença et al.
But it’s especially difficult in an industry like pharmaceuticals, due both to the sensitivity of the data and the severity of consequences that result from data management mistakes. Best practices for managing pharmaceutical data Again, there are no simple solutions for streamlining data management in the pharmaceutical industry.
Pharmaceutical companies are waging war against federal agencies over one of the Inflation Reduction Act’s major provisions allowing Medicare to negotiate 10 drugs to reduce out-of-pocket costs for | Legal experts question whether the Inflation Reduction Act is within its rights to enforce its drug pricing negotiation provision.
The Mayo Clinic and LifePoint Health believe that collusion within pharmaceutical industry forced their organizations to overpay for the multiple myeloma drug Revlimid, and are petitioning the cour | The health systems said agreements between Revlimid's owners, Celgene and Bristol-Myers Squibb, and other drugmakers that delayed full production (..)
In the rapidly evolving world of pharmaceuticals, artificial intelligence (AI) is emerging as a game-changer. This predictive capability can help pharmaceutical companies make informed decisions about whether to proceed with a trial, adjust the trial design, or even abandon a trial that is unlikely to succeed.
Previously, Adam Kautzner led pharmaceutical and retail network contracting and drug sourcing as vice president of supply chain for the PBM and Accredo Pharmacy.
The Biden administration is cracking down on pharmaceutical companies as part of its price-fighting measures under the Inflation Reduction Act. | The Biden Administration announced Thursday a list of 48 Part B drugs with prices that rose faster than the rate of inflation in the final quarter of 2023. Here's what they plan to do now.
healthcare providers to their patients, launched a pharmaceutical pilot to identify doctors whose patient treatment plans are at risk of lapsing due to costs. Rochester, Michigan-based OptimizeRx Corp., which provides care-focused engagement throughout patient journeys and connects more than 60% of U.S.
But a tricky dosing regimen, as well as safety concerns, could challenge the pharmaceutical giant's lofty forecast. Bristol Myers paid $13 billion to acquire the drug's maker, MyoKardia, and expects it to become a blockbuster.
The guidance fills in details for one of the central pharmaceutical provisions of the Inflation Reduction Act, signaling how the agency will use its new authority.
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful biotechs contend with a healthcare system that’s long favored opioids?
Several groups have been granted additional time to comply with the more than 10-year-old legislation, which requires complete end-to-end supply chain visibility for pharmaceutical products.
They can quickly be integrated into manufacturing lines, which means embedded RFID technologies are no longer hindering pharmaceutical manufacturing. “It ensures all parties can easily interact with pharmaceutical products at any point in the supply chain, resulting in a more cohesive and efficient ecosystem.”
The American Telemedicine Association, the College of Healthcare Information Management Executives (CHIME) and Otsuka America Pharmaceutical are among the groups in support of the Centers for Medic | Organizations signed a letter pledging support for a CMS-backed transitional coverage for emergency technologies pathway, which they say could improve (..)
The biotech claims its rivals’ vaccine Comirnaty, one of the world’s top-selling pharmaceutical products, infringes on two patents covering its messenger RNA technology.
The health insurer’s national formulary considers Amylyx Pharmaceuticals’ Relyvrio to be "experimental, investigational or unproven for any use,” and now does not recommend covering it.
Matching patients to clinical trials they are eligible for has been a major challenge for everyone from pharmaceutical companies to hospitals. We also worked with a large pharmaceutical company to validate the problem area and solution design." THE PROBLEM. " RESULTS.
In a federal lawsuit, AARP is supporting Medicare’s new ability to negotiate drug prices with pharmaceutical companies, ahead of CMS naming the first 10 prescription drugs next month. The nation’s leading lobbying group for older Americans is supporting the U.S. |
What You Should Know: AstraZeneca has entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs).
Doximity, a digital platform for medical professionals, cut its workforce by 10%, or 100 employee positions, and downgraded its revenue guidance as it faces economic pressures and slowing sales am | Doximity, a digital platform for medical professionals, cut its workforce by 10%, or 100 employee positions, and downgraded its revenue guidance as it (..)
Sun Pharma probes cyber breach Indian pharma giant Sun Pharmaceutical Industries has reported an "information security incident," according to PTI. The news report noted that the company has already reported the incident to the authorities and has since isolated its affected IT assets.
What You Should Know: – The American Brain Foundation has launched a $10 million cross-disciplinary research initiative that transcends traditional research and philanthropy boundaries by bringing together nonprofit organizations, pharmaceutical and biotech investors, philanthropists, and researchers.
of individuals >15 were daily smokers Alcohol use : 6% of adults regularly engage in heavy drinking (below EU average of 18.5%) [link] Healthcare spending Healthcare spending : €132 billion (as of 2021) Healthcare spending as a share of GDP : 10.8% (as of 2021) Pharmaceutical spending : €12.7 Country overview Population : 48.4
Smart Pharmacies AIs data analyzing and automation skills have a lot of power in pharmaceutical settings, too. AI in the pharmaceutical sector can keep patients healthier. When physician-approved and trained AI is available all the time, patients are more likely to remain engaged with their healthcare plan.
This collaboration also introduces a transformative approach to patient marketing, particularly for pharmaceutical companies. By targeting the “invisible patient”—those undiagnosed individuals navigating complex health issues—this partnership allows companies to engage with a previously difficult-to-reach patient population.
Atropos Health's Evidence Network has grown to include the data resources of pharmaceutical-focused Forian and international patient data resources from Syndesis. The two new additions, Forian and Syndesis, will bring more pharmaceutical and international patient data to users of the network.
Pharmaceutical costs, non-claims payments and outpatient care fueled “unchecked” healthcare spending in Massachusetts that's increasingly being felt by its residents, according to new findings from | The Bay State's healthcare cost growth benchmark program is calling for policy action after a report showed per-person health spending well (..)
Historically, care management services have focused on clinical disease management, patient education, appointment navigation and pharmaceutical adherence issues that chronically ill patients face each day.
Partnership Opportunities: Provides consumer health and pharmaceutical brands with a new channel to reach a wider audience through the GoodRx platform. Affordability: GoodRx leverages its expertise in prescription savings to offer competitive prices on OTC products.
" Eriksson, a psychiatrist by training, has been working in the pharmaceutical industry for more than 20 years. Hans Eriksson, chief clinical development officer at HMNC Brain Health, in an interview with Healthcare IT News. "It has very much been a one-size-fits-all [approach] in the pharma industry."
Advanced Therapy Management, to provide pharmaceutical companies with visibility into the use of patient therapies, from referrals and appointment scheduling to drug manufacturing. Digital marketplaces, which are available to pharmaceutical and medical device companies in the ecosystem to sell products and offer subscriptions.
However, while DTP technology could empower patients to advocate for the best possible treatment options, members of Congress and others are concerned about the potential conflict of interest for pharmaceutical companies offering direct sales. Lawmakers recently asked pharmaceutical companies questions about their tapping into virtual care.
We organize all of the trending information in your field so you don't have to. Join 19,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content